Demand and supply of certain types of medtech, industrial operations, supply chains and distribution systems were all impacted, to a greater or lesser extent, by COVID-19 in 2020. So were product development milestones, clinical trials, regulatory clearances and approval timings.
All companies were affected one way or another. Most leading orthopedic and some cardiology suppliers often saw sharply negative outcomes,...






